Ernexa Therapeutics (ERNAW) Shares Outstanding (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 17 years of Shares Outstanding (Entity) data on file, last reported at $792000.0 in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 468.45% year-over-year to $792000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $792000.0 (up 468.45% YoY) and the FY2025 annual result came in at $252280.0, up 593.19% from the prior year.
• Shares Outstanding (Entity) climbed to $792000.0 in Q1 2026, from $252280.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $792000.0 in Q1 2026 to a low of $7.0 in Q1 2022.
• A 5-year average of $109706.7 and a median of $14427.0 in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) plunged 99.81% — and 2023, when it surged 195228.57%.
• Tracing ERNAW's Shares Outstanding (Entity) over 5 years: stood at $8136.0 in 2022, then soared by 77.32% to $14427.0 in 2023, then soared by 152.26% to $36394.0 in 2024, then soared by 593.19% to $252280.0 in 2025, then jumped by 213.94% to $792000.0 in 2026.
• The last three Shares Outstanding (Entity) figures came in at $792000.0 (Q1 2026), $252280.0 (Q4 2025), and $313960.0 (Q3 2025), per Business Quant data.